Sunday - June 23, 2024
Senate Judiciary Committee Issues Testimony From PhRMA VP Ulrich (Part 2 of 2)
June 05, 2024
WASHINGTON, June 5 -- The Senate Judiciary Committee released the following testimony by Jocelyn Ulrich, vice president of policy and research at PhRMA, from a hearing dated May 21, 2024, entitled "Ensuring Affordable & Accessible Medications: Examining Competition in the Prescription Drug Market":

* * *

According to Harvard researchers, "the most insidious effect of 340B...is the incentive it gives clinics to prescribe high-cost medications, even whe . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products